Dennis A Carson Selected Research

Etodolac (Lodine)

10/2015	A window-of-opportunity biomarker study of etodolac in resectable breast cancer.
2/2005	The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis.
6/2004	Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARgamma.
1/2004	Apoptosis induced by molecular targeting therapy in hematological malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dennis A Carson Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 09/2002
8	Infections 01/2021 - 08/2006
7	Inflammation (Inflammations) 01/2021 - 01/2002
6	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2014
6	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2011
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2015 - 01/2004
4	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 02/2009
4	Rheumatoid Arthritis 01/2020 - 11/2002
4	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2005
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 12/2014
3	Carcinogenesis 01/2020 - 03/2004
3	Leukemia 06/2015 - 06/2003
3	Arthritis (Polyarthritis) 08/2014 - 01/2002
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2017 - 09/2002
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2012 - 10/2004
2	Melanoma (Melanoma, Malignant) 02/2011 - 10/2007
2	Prostatic Neoplasms (Prostate Cancer) 02/2005 - 06/2004
1	Serous Cystadenocarcinoma 01/2022
1	Alcoholic Hepatitis 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Colonic Neoplasms (Colon Cancer) 06/2020
1	Weight Loss (Weight Reduction) 11/2019
1	Splenomegaly 11/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Lewis Lung Carcinoma 01/2018
1	Experimental Melanoma 01/2018

Drug/Important Bio-Agent (IBA)

11	LigandsIBA 01/2021 - 01/2002
11	Pharmaceutical PreparationsIBA 01/2020 - 01/2004
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
9	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 07/2008
6	VaccinesIBA 01/2021 - 03/2015
6	Toll-Like Receptor 7IBA 01/2021 - 07/2008
5	Pattern Recognition ReceptorsIBA 01/2022 - 10/2007
5	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2004
5	CytokinesIBA 01/2021 - 01/2003
5	Cyclin D1IBA 11/2016 - 09/2002
4	Phosphotransferases (Kinase)IBA 01/2022 - 06/2004
4	CateninsIBA 01/2019 - 08/2011
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018 - 02/2011
4	Etodolac (Lodine)FDA LinkGeneric 10/2015 - 01/2004
4	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 01/2002
4	beta CateninIBA 12/2009 - 09/2002
3	AntigensIBA 01/2022 - 11/2019
3	ChemokinesIBA 01/2020 - 01/2003
3	Toll-Like Receptor AgonistsIBA 01/2020 - 01/2017
2	Frizzled ReceptorsIBA 01/2022 - 09/2002
2	Vaccine AdjuvantsIBA 01/2021 - 01/2020
2	InterferonsIBA 06/2020 - 12/2016
2	Cancer VaccinesIBA 01/2020 - 12/2016
2	EnzymesIBA 12/2019 - 10/2015
2	Peptides (Polypeptides)IBA 10/2019 - 01/2012
2	TCF Transcription FactorsIBA 01/2019 - 09/2002
2	Monoclonal AntibodiesIBA 01/2019 - 01/2012
2	salinomycinIBA 01/2019 - 08/2011
2	cirmtuzumabIBA 01/2019 - 12/2014
2	RNA IsoformsIBA 06/2015 - 01/2013
2	Neutralizing AntibodiesIBA 03/2015 - 08/2006
2	Imiquimod (Aldara)FDA LinkGeneric 09/2013 - 05/2010
2	Diphosphonates (Bisphosphonates)IBA 04/2012 - 07/2011
2	NitrogenIBA 04/2012 - 07/2011
2	Fibronectins (Fibronectin)IBA 08/2011 - 11/2002
2	Viral RNAIBA 07/2008 - 10/2007
2	AntibodiesIBA 02/2008 - 09/2002
1	2D216IBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Interleukin-22 (IL-22)IBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	AntioxidantsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	antineoplaston A10 (A 10)IBA 06/2020
1	Programmed Cell Death 1 ReceptorIBA 06/2020
1	GlucocorticoidsIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	SugarsIBA 01/2020
1	Transcription Factor 4IBA 01/2020
1	OvalbuminIBA 11/2019
1	1V209IBA 11/2019
1	Isoantigens (Alloantigen)IBA 10/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	matrigelIBA 01/2019
1	CarcinogensIBA 01/2018
1	TubulinIBA 01/2018

Therapy/Procedure

12	Therapeutics 01/2021 - 09/2002
9	Immunotherapy 01/2022 - 09/2002
4	Drug Therapy (Chemotherapy) 01/2019 - 01/2013
2	Intranasal Administration 01/2018 - 02/2008
1	Oral Administration 01/2021
1	Ablation Techniques 10/2019